Skip to main content
. 2024 Jun 28;63(6):2400518. doi: 10.1183/13993003.00518-2024

FIGURE 1.

FIGURE 1

Summary of management points and ongoing studies (ClinicalTrials.gov and ISRCTN) in bronchiectasis. HRCT: high-resolution computed tomography; NTM-PD: non-tuberculous mycobacterial pulmonary disease; ABPA: allergic bronchopulmonary aspergillosis; IL: interleukin; i.v.: intravenous; T2: type 2; s.c.: subcutaneous; CFTR: cystic fibrosis transmembrane conductance regulator; ENaC: epithelial sodium channel; PCD: primary ciliary dyskinesia.